|Articles|May 23, 2022

Clario and Cogstate Expand Partnership

Clario announced an expansion of its partnership with cognitive science company, Cogstate, to jointly provide data quality solutions to support the unique requirements of neuroscience assessments for therapeutic development.

Trending on Applied Clinical Trials Online

Clario and Cogstate Expand Partnership

Related Content

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps

Trending on Applied Clinical Trials Online

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps

Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work